SCHEMBL6993090

SCHEMBL6993090

N#Cc1cccc(NC(=O)NC(CCN2CCC(CCc3ccccc3)CC2)c2ccccc2)c1

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CCR3 P51677 19/20 0.59
HTR2A P28223 3/20 0.58
CCR5 P51681 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6217778 0.91 CCR3 (0.71) CCR3HTR2ACCR5
SCHEMBL6329419 0.86 CCR3 (0.69) CCR3HTR2A
SCHEMBL6331131 0.76 CCR3 (0.69) CCR3HTR2A
SCHEMBL6330867 0.75 CCR3 (0.84) CCR3HTR2A
SCHEMBL7813834 0.74 CCR3 (0.72) CCR3HTR2A
SCHEMBL6215640 0.73 CCR3 (1.00) CCR3HTR2A
SCHEMBL6333237 0.73 CCR3 (0.61) CCR3CCR5
SCHEMBL6993094 0.73 CCR3 (0.62) CCR3HTR2A
SCHEMBL6337783 0.73 CCR3 (1.00) CCR3HTR2A
SCHEMBL6701753 0.72 CCR3 (1.00) CCR3HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363881-A2 N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Pharma Company (US) 2003-11-26 EP disclosed
WO-2001098269-A2 N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-12-27 WO disclosed